Newsletter

Healthcare Stocks

Monash IVF (ASX:MVF) Rises on Another Profit Cut: Buy the Dip or Value Trap?

KEY POINTS Monash IVF (ASX: MVF) cut its FY26 profit forecast again, to between A$17 million and A$18 million, as fewer Australians start IVF. The shares actually rose on the news (up 2.24% to A$0.68), a sign the bad news was already expected. A A$0.90 takeover bid from the Soul Patts and…

ByUjjwal MaheshwariJune 13, 2026

OncoSil Medical (ASX:OSL) flags a catalyst-heavy back half of 2026

OncoSil Medical (ASX:OSL) launched a new Investor Hub and flagged a catalyst-rich second half of 2026 spanning FDA, clinical and manufacturing milestones.

ByCharlie YouldenJune 12, 2026

Microba (ASX:MAP) raises A$5m and Sonic Healthcare keeps writing cheques

Microba Life Sciences (ASX:MAP) raises A$5m at a 20.6% discount with Sonic Healthcare backing the round, targeting CY2027 cashflow break-even.

ByCharlie YouldenJune 12, 2026

Vitrafy (ASX:VFY) raises A$30m at a 31.6% discount to chase 2027

Vitrafy Life Sciences (ASX:VFY) raises A$30m at a 31.6% discount to scale US operations ahead of the 2027 blood industry cryopreservation deadline.

ByCharlie YouldenJune 12, 2026

Vitasora (ASX:VHL) closes A$4m raise at 2.7x target as billings jump 70%

Vitasora Health (ASX:VHL) closed a A$4 million placement at 2.7x its target, cornerstoned by a A$3 million cheque from Bob Peters.

ByCharlie YouldenJune 11, 2026

Sigma Healthcare (ASX:SIG) Falls 5.5% on Boots Bid Talks: Overreaction or Red Flag?

KEY POINTS Sigma Healthcare (ASX: SIG) shares fell about 5.5% to A$2.76 after the company confirmed early talks to buy UK chemist chain Boots, a deal valued at around US$10 billion (roughly A$15 billion). The market sold off because Sigma is still bedding down its huge Chemist Warehouse merger and only entered the…

ByUjjwal MaheshwariJune 10, 2026

LTR Pharma (ASX:LTP) lands 150,000-unit ROXUS deal that anchors the US story

LTR Pharma (ASX:LTP) signs a binding US telehealth term sheet with Shed Holdings, locking in a 150,000-unit ROXUS minimum volume floor.

ByCharlie YouldenJune 9, 2026

CSL (ASX:CSL) Jumps 5.7% as Investors Pile Back Into Healthcare

KEY POINTS CSL (ASX: CSL) jumped 5.7% to A$97.91 on Friday, its best day since February 2022. Healthcare was the real story, rising 3.5% as money moved out of miners and into the sector. CSL is still down nearly 60% over the year after profit warnings, a CEO change, and about US$5…

ByUjjwal MaheshwariJune 6, 2026